Small molecule regulation of Sir2 protein deacetylases

The Sir2 family of histone/protein deacetylases (sirtuins) is comprised of homologues found across all kingdoms of life. These enzymes catalyse a unique reaction in which NAD+ and acetylated substrate are converted into deacetylated product, nicotinamide, and a novel metabolite O‐acetyl ADP‐ribose....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The FEBS journal 2005-09, Vol.272 (18), p.4607-4616
Hauptverfasser: Grubisha, Olivera, Smith, Brian C., Denu, John M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4616
container_issue 18
container_start_page 4607
container_title The FEBS journal
container_volume 272
creator Grubisha, Olivera
Smith, Brian C.
Denu, John M.
description The Sir2 family of histone/protein deacetylases (sirtuins) is comprised of homologues found across all kingdoms of life. These enzymes catalyse a unique reaction in which NAD+ and acetylated substrate are converted into deacetylated product, nicotinamide, and a novel metabolite O‐acetyl ADP‐ribose. Although the catalytic mechanism is well conserved across Sir2 family members, sirtuins display differential specificity toward acetylated substrates, which translates into an expanding range of physiological functions. These roles include control of gene expression, cell cycle regulation, apoptosis, metabolism and ageing. The dependence of sirtuin activity on NAD+ has spearheaded investigations into how these enzymes respond to metabolic signals, such as caloric restriction. In addition, NAD+ metabolites and NAD+ salvage pathway enzymes regulate sirtuin activity, supporting a link between deacetylation of target proteins and metabolic pathways. Apart from physiological regulators, forward chemical genetics and high‐throughput activity screening has been used to identify sirtuin inhibitors and activators. This review focuses on small molecule regulators that control the activity and functions of this unusual family of protein deacetylases.
doi_str_mv 10.1111/j.1742-4658.2005.04862.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68583964</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68583964</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3992-b1b691f8cbdc15c547a34db2de34cd1e9a6efc2f1aeca063e86783ea25b769c53</originalsourceid><addsrcrecordid>eNqNkEtLw0AQgBdRbK3-BcnJW-K-s3sRtLQqFDxUwduy2UwkZdPUbILtvzexpR51LjMw3zz4EIoITkgft6uEpJzGXAqVUIxFgrmSNNmeoPGxcXqs-fsIXYSwwpgJrvU5GhFJhEwVGyO5rKz3UVV7cJ2HqIGPztu2rNdRXUTLsqHRpqlbKNdRDtZBu_M2QLhEZ4X1Aa4OeYLe5rPX6VO8eHl8nt4vYse0pnFGMqlJoVyWOyKc4KllPM9oDoy7nIC2EgpHC2LBWSwZqOErsFRkqdROsAm62e_tn_jsILSmKoMD7-0a6i4YqYRiWvI_QZIKJaTGPaj2oGvqEBoozKYpK9vsDMFmkGtWZvBmBodmkGt-5JptP3p9uNFlFeS_gwebPXC3B75KD7t_Lzbz2cNyKNk3rKyIug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17585690</pqid></control><display><type>article</type><title>Small molecule regulation of Sir2 protein deacetylases</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><source>IngentaConnect Open Access Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Grubisha, Olivera ; Smith, Brian C. ; Denu, John M.</creator><creatorcontrib>Grubisha, Olivera ; Smith, Brian C. ; Denu, John M.</creatorcontrib><description>The Sir2 family of histone/protein deacetylases (sirtuins) is comprised of homologues found across all kingdoms of life. These enzymes catalyse a unique reaction in which NAD+ and acetylated substrate are converted into deacetylated product, nicotinamide, and a novel metabolite O‐acetyl ADP‐ribose. Although the catalytic mechanism is well conserved across Sir2 family members, sirtuins display differential specificity toward acetylated substrates, which translates into an expanding range of physiological functions. These roles include control of gene expression, cell cycle regulation, apoptosis, metabolism and ageing. The dependence of sirtuin activity on NAD+ has spearheaded investigations into how these enzymes respond to metabolic signals, such as caloric restriction. In addition, NAD+ metabolites and NAD+ salvage pathway enzymes regulate sirtuin activity, supporting a link between deacetylation of target proteins and metabolic pathways. Apart from physiological regulators, forward chemical genetics and high‐throughput activity screening has been used to identify sirtuin inhibitors and activators. This review focuses on small molecule regulators that control the activity and functions of this unusual family of protein deacetylases.</description><identifier>ISSN: 1742-464X</identifier><identifier>EISSN: 1742-4658</identifier><identifier>DOI: 10.1111/j.1742-4658.2005.04862.x</identifier><identifier>PMID: 16156783</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>deacetylation ; Enzyme Activation ; Enzyme Inhibitors ; NAD ; NAD - metabolism ; resveratrol ; Sir2 ; sirtinol ; sirtuin ; Sirtuins - agonists ; Sirtuins - antagonists &amp; inhibitors ; Sirtuins - physiology ; splitomicin</subject><ispartof>The FEBS journal, 2005-09, Vol.272 (18), p.4607-4616</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3992-b1b691f8cbdc15c547a34db2de34cd1e9a6efc2f1aeca063e86783ea25b769c53</citedby><cites>FETCH-LOGICAL-c3992-b1b691f8cbdc15c547a34db2de34cd1e9a6efc2f1aeca063e86783ea25b769c53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1742-4658.2005.04862.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1742-4658.2005.04862.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16156783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grubisha, Olivera</creatorcontrib><creatorcontrib>Smith, Brian C.</creatorcontrib><creatorcontrib>Denu, John M.</creatorcontrib><title>Small molecule regulation of Sir2 protein deacetylases</title><title>The FEBS journal</title><addtitle>FEBS J</addtitle><description>The Sir2 family of histone/protein deacetylases (sirtuins) is comprised of homologues found across all kingdoms of life. These enzymes catalyse a unique reaction in which NAD+ and acetylated substrate are converted into deacetylated product, nicotinamide, and a novel metabolite O‐acetyl ADP‐ribose. Although the catalytic mechanism is well conserved across Sir2 family members, sirtuins display differential specificity toward acetylated substrates, which translates into an expanding range of physiological functions. These roles include control of gene expression, cell cycle regulation, apoptosis, metabolism and ageing. The dependence of sirtuin activity on NAD+ has spearheaded investigations into how these enzymes respond to metabolic signals, such as caloric restriction. In addition, NAD+ metabolites and NAD+ salvage pathway enzymes regulate sirtuin activity, supporting a link between deacetylation of target proteins and metabolic pathways. Apart from physiological regulators, forward chemical genetics and high‐throughput activity screening has been used to identify sirtuin inhibitors and activators. This review focuses on small molecule regulators that control the activity and functions of this unusual family of protein deacetylases.</description><subject>deacetylation</subject><subject>Enzyme Activation</subject><subject>Enzyme Inhibitors</subject><subject>NAD</subject><subject>NAD - metabolism</subject><subject>resveratrol</subject><subject>Sir2</subject><subject>sirtinol</subject><subject>sirtuin</subject><subject>Sirtuins - agonists</subject><subject>Sirtuins - antagonists &amp; inhibitors</subject><subject>Sirtuins - physiology</subject><subject>splitomicin</subject><issn>1742-464X</issn><issn>1742-4658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtLw0AQgBdRbK3-BcnJW-K-s3sRtLQqFDxUwduy2UwkZdPUbILtvzexpR51LjMw3zz4EIoITkgft6uEpJzGXAqVUIxFgrmSNNmeoPGxcXqs-fsIXYSwwpgJrvU5GhFJhEwVGyO5rKz3UVV7cJ2HqIGPztu2rNdRXUTLsqHRpqlbKNdRDtZBu_M2QLhEZ4X1Aa4OeYLe5rPX6VO8eHl8nt4vYse0pnFGMqlJoVyWOyKc4KllPM9oDoy7nIC2EgpHC2LBWSwZqOErsFRkqdROsAm62e_tn_jsILSmKoMD7-0a6i4YqYRiWvI_QZIKJaTGPaj2oGvqEBoozKYpK9vsDMFmkGtWZvBmBodmkGt-5JptP3p9uNFlFeS_gwebPXC3B75KD7t_Lzbz2cNyKNk3rKyIug</recordid><startdate>200509</startdate><enddate>200509</enddate><creator>Grubisha, Olivera</creator><creator>Smith, Brian C.</creator><creator>Denu, John M.</creator><general>Blackwell Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>200509</creationdate><title>Small molecule regulation of Sir2 protein deacetylases</title><author>Grubisha, Olivera ; Smith, Brian C. ; Denu, John M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3992-b1b691f8cbdc15c547a34db2de34cd1e9a6efc2f1aeca063e86783ea25b769c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>deacetylation</topic><topic>Enzyme Activation</topic><topic>Enzyme Inhibitors</topic><topic>NAD</topic><topic>NAD - metabolism</topic><topic>resveratrol</topic><topic>Sir2</topic><topic>sirtinol</topic><topic>sirtuin</topic><topic>Sirtuins - agonists</topic><topic>Sirtuins - antagonists &amp; inhibitors</topic><topic>Sirtuins - physiology</topic><topic>splitomicin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grubisha, Olivera</creatorcontrib><creatorcontrib>Smith, Brian C.</creatorcontrib><creatorcontrib>Denu, John M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The FEBS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grubisha, Olivera</au><au>Smith, Brian C.</au><au>Denu, John M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Small molecule regulation of Sir2 protein deacetylases</atitle><jtitle>The FEBS journal</jtitle><addtitle>FEBS J</addtitle><date>2005-09</date><risdate>2005</risdate><volume>272</volume><issue>18</issue><spage>4607</spage><epage>4616</epage><pages>4607-4616</pages><issn>1742-464X</issn><eissn>1742-4658</eissn><abstract>The Sir2 family of histone/protein deacetylases (sirtuins) is comprised of homologues found across all kingdoms of life. These enzymes catalyse a unique reaction in which NAD+ and acetylated substrate are converted into deacetylated product, nicotinamide, and a novel metabolite O‐acetyl ADP‐ribose. Although the catalytic mechanism is well conserved across Sir2 family members, sirtuins display differential specificity toward acetylated substrates, which translates into an expanding range of physiological functions. These roles include control of gene expression, cell cycle regulation, apoptosis, metabolism and ageing. The dependence of sirtuin activity on NAD+ has spearheaded investigations into how these enzymes respond to metabolic signals, such as caloric restriction. In addition, NAD+ metabolites and NAD+ salvage pathway enzymes regulate sirtuin activity, supporting a link between deacetylation of target proteins and metabolic pathways. Apart from physiological regulators, forward chemical genetics and high‐throughput activity screening has been used to identify sirtuin inhibitors and activators. This review focuses on small molecule regulators that control the activity and functions of this unusual family of protein deacetylases.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>16156783</pmid><doi>10.1111/j.1742-4658.2005.04862.x</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1742-464X
ispartof The FEBS journal, 2005-09, Vol.272 (18), p.4607-4616
issn 1742-464X
1742-4658
language eng
recordid cdi_proquest_miscellaneous_68583964
source MEDLINE; Wiley Online Library Journals; IngentaConnect Open Access Journals; Free Full-Text Journals in Chemistry
subjects deacetylation
Enzyme Activation
Enzyme Inhibitors
NAD
NAD - metabolism
resveratrol
Sir2
sirtinol
sirtuin
Sirtuins - agonists
Sirtuins - antagonists & inhibitors
Sirtuins - physiology
splitomicin
title Small molecule regulation of Sir2 protein deacetylases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A07%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Small%20molecule%20regulation%20of%20Sir2%20protein%20deacetylases&rft.jtitle=The%20FEBS%20journal&rft.au=Grubisha,%20Olivera&rft.date=2005-09&rft.volume=272&rft.issue=18&rft.spage=4607&rft.epage=4616&rft.pages=4607-4616&rft.issn=1742-464X&rft.eissn=1742-4658&rft_id=info:doi/10.1111/j.1742-4658.2005.04862.x&rft_dat=%3Cproquest_cross%3E68583964%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17585690&rft_id=info:pmid/16156783&rfr_iscdi=true